News & Updates

For three decades, hypertension-related cardiovascular disease (CVD) burden in young adults has substantially rose, with spatiotemporal and sexual heterogeneity, according to a study. Middle-income countries bear the heaviest burden, particularly men.

Exercise systolic blood pressure (SBP) is linked to several cardiovascular risk factors, which tend to be worse in individuals with a hypertensive response to exercise (HRE), reveals a study.

The use of amphilimus-eluting stents (AES) in patients with diabetes mellitus undergoing percutaneous revascularization was less likely to result in target lesion or target vessel failure compared with zotarolimus-eluting stents (ZES) at 1 year, according to findings of the SUGAR trial presented at TCT 2021.

Treatment with the nonsteroidal mineralocorticoid receptor antagonist finerenone helps prevent the incidence of new-onset heart failure (HF) and improve other HF outcomes among patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), as shown in a secondary analysis of the phase III FIGARO-DKD trial.